What is the first line of treatment for an active seizure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Active Seizure

The first-line treatment for an active seizure is intravenous lorazepam at a dose of 0.1 mg/kg (maximum 4 mg) administered slowly at 2 mg/minute. 1, 2, 3

Initial Management of Active Seizure

  1. Immediate First Aid Measures:

    • Help the person to the ground
    • Place the person on their side in recovery position
    • Clear the area around them to prevent injury
    • Stay with the person having a seizure 4
  2. When to Activate EMS:

    • First-time seizure
    • Seizures lasting >5 minutes
    • Multiple seizures without return to baseline between episodes
    • Seizures occurring in water
    • Seizures with traumatic injuries or difficulty breathing
    • Seizure in an infant <6 months of age
    • Seizure in pregnant individuals
    • If the person doesn't return to baseline within 5-10 minutes after seizure activity stops 4
  3. DO NOT:

    • Restrain the person
    • Put anything in the mouth
    • Give food, liquids, or oral medicines during a seizure or when responsiveness is decreased 4

Medication Protocol for Active Seizure

First-Line Treatment:

  • Lorazepam 0.1 mg/kg IV (maximum 4 mg) administered at 2 mg/minute 1, 2, 3
  • If seizures continue or recur after 10-15 minutes, an additional 4 mg IV dose may be administered 2

Alternative Routes When IV Access Unavailable:

  • Intramuscular midazolam (effective alternative to IV lorazepam) 1, 5
  • Buccal midazolam (approved in EU) 6
  • Rectal diazepam (FDA-approved for out-of-hospital treatment) 6

Second-Line Treatment (if seizures persist):

  • Fosphenytoin 20 mg phenytoin equivalents/kg IV at a rate not exceeding 150 mg/minute 7
  • Alternative options include:
    • Valproate 20-30 mg/kg IV (88% success rate)
    • Levetiracetam 30-50 mg/kg IV (44-73% success rate)
    • Phenobarbital 10-20 mg/kg IV (58% success rate) 1

Third-Line Treatment (for refractory status epilepticus):

  • If seizures continue, initiate intravenous general anesthesia with:
    • Pentobarbital
    • Benzodiazepine drip
    • Propofol 7

Special Considerations

  1. Equipment Preparation:

    • Equipment to maintain a patent airway must be immediately available prior to benzodiazepine administration 2
    • Start an IV infusion, monitor vital signs, maintain unobstructed airway, and have artificial ventilation equipment available 2
  2. Monitoring:

    • Continuous cardiorespiratory monitoring
    • Frequent neurological assessments
    • EEG monitoring for patients who do not recover consciousness 1, 7
  3. Potential Adverse Effects:

    • Respiratory depression (especially when combined with other sedative agents)
    • Hypotension
    • Sedation 1, 2
  4. Pediatric Considerations:

    • Febrile seizures are common in children 6 months to 2 years of age
    • Antipyretics (acetaminophen, ibuprofen) are not effective for stopping or preventing febrile seizures 4

Remember that status epilepticus (seizures lasting >5 minutes or multiple seizures without return to baseline) is a medical emergency requiring aggressive treatment to prevent neuronal damage. The time to treatment is crucial, as clinical response to benzodiazepines diminishes with prolonged status epilepticus 5.

References

Guideline

Seizure Management and Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The Role of Benzodiazepines in the Treatment of Epilepsy.

Current treatment options in neurology, 2016

Research

Convulsive Status Epilepticus.

Current treatment options in neurology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.